Drawing for J&J

USPTO serial 98179228

J&J

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
JANSON, ANDREW KYLE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with J&J?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $599*

Plus Government fees of $500

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David McDonald

David McDonald JOHNSON & JOHNSONONE JOHNSON & JOHNSON PLAZANEW BRUNSWICK, NJ 08933United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers; chemical, biochemical and biological preparations and agents for medical purposes, namely for use in orthopedic surgeries; diagnostic preparations for medical use; medical dressings; hemostatic agents for surgical use; drug delivery agents in the form of compounds, capsules, powders, dissolvable films, or liquids that facilitate the delivery of a wide range of pharmaceuticals and pharmaceutical preparations; contact lens disinfecting, cleaning, storing and rewetting solutionsACTIVE—
009Downloadable and recorded computer software for accessing information related to all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical products of all kinds; optical lenses for vision correction; contact lenses; eyeglass lensesACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments; artificial limbs, eyes and teeth; orthopedic articles, namely, shoulder, hip, knee, spine, foot and ankle prostheses; suture materials; surgical robots and surgical robotic instruments; surgical visualization systems comprised primarily of medical imaging apparatus for use in surgical procedures and also incorporating computer hardware and display montiors for video processing and image management during surgical proceduresACTIVE—
042Scientific research for medical and healthcare purposes; research and development services in the fields of drug discovery, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting clinical trials for others; scientific research consulting; providing scientific information in the field of laboratory technology; medical laboratory services; medical and pharmacological research services; providing online non-downloadable computer software for accessing information related to all aspects of health, personal care, nutrition, wellness, and the development and use of pharmaceuticals, medicaments and medical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 27, 2026EX3GSOU EXTENSION 3 GRANTED—
Mar 27, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 26, 2026EXT3SOU EXTENSION 3 FILED—
Oct 7, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 7, 2025EX2GSOU EXTENSION 2 GRANTED—
Oct 3, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 2, 2025EXT2SOU EXTENSION 2 FILED—
Oct 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2025NOACCORRECTED NOA E-MAILED—
Oct 2, 2025DPCCDIVISIONAL PROCESSING COMPLETE—
Oct 2, 2025EX1GSOU EXTENSION 1 GRANTED—
Sep 3, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 16, 2025DRRRDIVISIONAL REQUEST RECEIVED—
Apr 16, 2025EXT1SOU EXTENSION 1 FILED—
Apr 16, 2025ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Apr 16, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 22, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 27, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 18, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 18, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 18, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 18, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 26, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 26, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2024DOCKASSIGNED TO EXAMINER—
Oct 3, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 18, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance